MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells	https://doi.org/10.1007/s12031-017-1017-7	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis	https://doi.org/10.1016/j.biopha.2018.08.020	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101	https://doi.org/10.1016/j.ejphar.2018.11.028	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways	https://doi.org/10.1016/j.exer.2014.02.017	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma	https://doi.org/10.1038/eye.2016.189	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma	https://doi.org/10.1101/gad.17027411	2011	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells	https://doi.org/10.1167/iovs.09-3520	2009	Cell line 2 Master/Detail View	Cell line and drug 3 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
-EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression	https://doi.org/10.1371/journal.pone.0114800	2014	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
-EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression	https://doi.org/10.1371/journal.pone.0114800	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Downregulation of microRNA182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation	https://doi.org/10.3892/ijo.2018.4587	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/kRas/Raf/MEK/ERK signaling pathway	https://doi.org/10.3892/ijo.2019.4689	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Evaluation of SD-208, a TGF-beta-RI Kinase Inhibitor, as an Anticancer Agent in Retinoblastoma	https://doi.org/	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway	https://doi.org/10.1002/cbin.10678	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells	https://doi.org/10.1182/blood-2006-09-045104	2007	Cell line 0 Master/Detail View	Cell line and drug 7 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma	https://doi.org/10.3233/cbm-170721	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression	https://doi.org/10.1016/j.biopha.2016.05.003	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation	https://doi.org/10.1371/journal.pone.0138366	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Blocking the maturation of OncomiRNAs using pri-miRNA-17 approximately 92 aptamer in retinoblastoma	https://doi.org/10.1089/nat.2014.0507	2015	Cell line 7 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Effects of miR-26a on the expression of Beclin 1 in retinoblastoma cells	https://doi.org/10.4238/gmr.15028193	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma	https://doi.org/10.1016/j.biopha.2018.10.096	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications